SWIG
ABBV icon

Strategic Wealth Investment Group’s AbbVie ABBV Stock Holding History

Strategic Wealth Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.31M Sell
37,016
-5,374
-13% -$1.16M 1.13% 37
2026
Q1 		$9.22M Buy
42,390
+309
+0.7% +$68.5K 1.17% 38
2025
Q4 		$9.62M Sell
42,081
-16,820
-29% -$3.83M 1.18% 37
2025
Q3 		$13.6M Buy
58,901
+56,408
+2,263% +$11.5M 1.15% 35
2025
Q2 		$463K Buy
2,493
+299
+14% +$55.6K 0.67% 39
2025
Q1 		$460K Sell
2,194
-49,733
-96% -$9.67M 0.8% 36
2024
Q4 		$9.23M Buy
51,927
+1,010
+2% +$186K 1.02% 35
2024
Q3 		$10M Buy
50,917
+13,085
+35% +$2.44M 1.07% 39
2024
Q2 		$6.45M Buy
+37,832
New +$6.27M 0.81% 47
2023
Q4 		$790K Buy
5,097
+1,822
+56% +$266K 0.12% 61
2023
Q3 		$488K Sell
3,275
-1,590
-33% -$233K 0.09% 72
2023
Q2 		$655K Buy
4,865
+1,253
+35% +$184K 0.1% 82
2023
Q1 		$576K Buy
3,612
+188
+5% +$28.7K 0.11% 83
2022
Q4 		$511K Buy
3,424
+38
+1% +$5.83K 0.12% 71
2022
Q3 		$454K Buy
3,386
+414
+14% +$59.4K 0.13% 69
2022
Q2 		$455K Sell
2,972
-665
-18% -$102K 0.11% 93
2022
Q1 		$590K Buy
3,637
+7
+0.2% +$1.02K 0.14% 61
2021
Q4 		$492K Buy
3,630
+113
+3% +$13.3K 0.13% 62
2021
Q3 		$378K Buy
3,517
+6
+0.2% +$686 0.11% 63
2021
Q2 		$395K Buy
3,511
+108
+3% +$12.2K 0.14% 60
2021
Q1 		$368K Buy
3,403
+139
+4% +$14.9K 0.18% 57
2020
Q4 		$350K Sell
3,264
-62
-2% -$5.96K 0.21% 64
2020
Q3 		$291K Buy
3,326
+193
+6% +$18.2K 0.22% 70
2020
Q2 		$308K Sell
3,133
-141
-4% -$12.4K 0.3% 63
2020
Q1 		$249K Sell
3,274
-139
-4% -$11.8K 0.41% 38
2019
Q4 		$302K Buy
+3,413
New +$283K 0.31% 43

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Strategic Wealth Investment Group's ABBV Position: Q2 2026 in Review

Strategic Wealth Investment Group reduced its AbbVie (ABBV) stake by 13% in Q2 2026, selling an estimated $1.16M and leaving 37,016 shares worth $9.31M. The position accounts for 1.13% of the portfolio, ranked #37.

Strategic Wealth Investment Group first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $13.6M in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Strategic Wealth Investment Group held 37,016 shares of AbbVie worth $9.31M as of Q2 2026.
  • Strategic Wealth Investment Group sold 5,374 AbbVie shares in Q2 2026, an estimated $1.16M.
  • AbbVie made up 1.13% of Strategic Wealth Investment Group's portfolio in Q2 2026, its #37 holding.
  • Strategic Wealth Investment Group first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • Strategic Wealth Investment Group's AbbVie position peaked at $13.6M in Q3 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Strategic Wealth Investment Group's 13F filing for Q2 2026, filed 4 Aug 2026.